Annunziata, A.; Fiorentino, G.; Balestrino, M.; Rega, R.; Spinelli, S.; Atripaldi, L.; Sola, A.; Massaro, F.; Calabrese, C.
Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up? J. Clin. Med. 2024, 13, 1084.
https://doi.org/10.3390/jcm13041084
AMA Style
Annunziata A, Fiorentino G, Balestrino M, Rega R, Spinelli S, Atripaldi L, Sola A, Massaro F, Calabrese C.
Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up? Journal of Clinical Medicine. 2024; 13(4):1084.
https://doi.org/10.3390/jcm13041084
Chicago/Turabian Style
Annunziata, Anna, Giuseppe Fiorentino, Marco Balestrino, Roberto Rega, Sara Spinelli, Lidia Atripaldi, Alessio Sola, Federica Massaro, and Cecilia Calabrese.
2024. "Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up?" Journal of Clinical Medicine 13, no. 4: 1084.
https://doi.org/10.3390/jcm13041084
APA Style
Annunziata, A., Fiorentino, G., Balestrino, M., Rega, R., Spinelli, S., Atripaldi, L., Sola, A., Massaro, F., & Calabrese, C.
(2024). Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up? Journal of Clinical Medicine, 13(4), 1084.
https://doi.org/10.3390/jcm13041084